Skip to main content

Table 3 Government costs and lost tax revenue for three different AHP clinical scenarios (discounted at 3%)

From: Estimating the broader fiscal consequences of acute hepatic porphyria (AHP) with recurrent attacks in Belgium using a public economic analytic framework

 

GP

Scenario 1 AL-W

Change 1 (AL-W – GP)

Scenario 2 A10-W

Change 2 (A10-W – GP)

Scenario 3 A10 + W

Change 3 (A10 + W – GP)

Disability transfers

€40,277

€287,519

€247,242

€287,519

€247,242

€108,335

€68,058

Pension costs

€83,110

€83,110

€0

€83,110

€0

€83,110

€0

Health costs

€70,218

€3,100,534

€3,030,316

€1,589,502

€1,519,284

€1,589,502

€1,519,284

Sum of government costs

€193,605

€3,471,163

€3,277,558

€1,960,131

€1,766,526

€1,780,947

€1,587,342

Lifetime earnings

€632,367

€284,565

− €347,802

€284,565

− €347,802

€509,141

− €123,226

Gross tax

€434,722

€251,535

− €183,187

€251,535

− €183,187

€369,819

− €64,903

Work years

25.24

11.36

− 13.88

11.36

− 13.88

20.88

− 4.36

  1. AL-W, AHP attacks throughout life and unable to work
  2. A10-W, AHP attacks for 10 years, stopping at age 40, unable to work due to chronic comorbidities attributed to AHP
  3. A10 + W, AHP attacks for 10 years, stopping at age 40, able to return to work